Maxwell Sauder

736 total citations
34 papers, 221 citations indexed

About

Maxwell Sauder is a scholar working on Dermatology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Maxwell Sauder has authored 34 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 12 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Maxwell Sauder's work include Psoriasis: Treatment and Pathogenesis (7 papers), Dermatology and Skin Diseases (7 papers) and Autoimmune Bullous Skin Diseases (4 papers). Maxwell Sauder is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), Dermatology and Skin Diseases (7 papers) and Autoimmune Bullous Skin Diseases (4 papers). Maxwell Sauder collaborates with scholars based in Canada, United States and France. Maxwell Sauder's co-authors include Melanie D. Pratt, Steven J. Glassman, Nicole R. LeBoeuf, Jennifer Beecker, John T. O’Malley, Marcus O. Butler, Michele Ramien, Régis Vaillancourt, Nordau Kanigsberg and Daniel N. Sauder and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Maxwell Sauder

29 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maxwell Sauder Canada 9 118 48 45 43 42 34 221
Caitlin M. Brumfiel United States 8 146 1.2× 63 1.3× 57 1.3× 42 1.0× 22 0.5× 25 237
Rosa Fernández‐Torres Spain 11 143 1.2× 56 1.2× 91 2.0× 65 1.5× 42 1.0× 19 260
Alfred Ammoury Lebanon 12 172 1.5× 40 0.8× 57 1.3× 127 3.0× 37 0.9× 36 376
Khalad Maliyar Canada 9 185 1.6× 41 0.9× 101 2.2× 36 0.8× 20 0.5× 62 286
Lidija Kandolf Sekulović Serbia 8 120 1.0× 29 0.6× 63 1.4× 24 0.6× 71 1.7× 45 296
Cynthia Marie Carver DeKlotz United States 8 97 0.8× 46 1.0× 45 1.0× 46 1.1× 42 1.0× 34 271
Teresa Baudrier Portugal 10 56 0.5× 33 0.7× 22 0.5× 45 1.0× 20 0.5× 34 199
Kristina Hagenström Germany 9 135 1.1× 12 0.3× 44 1.0× 41 1.0× 27 0.6× 37 219
Л. С. Круглова Russia 5 110 0.9× 18 0.4× 64 1.4× 16 0.4× 16 0.4× 181 197
Filomena Russo Italy 9 92 0.8× 35 0.7× 56 1.2× 17 0.4× 18 0.4× 37 191

Countries citing papers authored by Maxwell Sauder

Since Specialization
Citations

This map shows the geographic impact of Maxwell Sauder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxwell Sauder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxwell Sauder more than expected).

Fields of papers citing papers by Maxwell Sauder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxwell Sauder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxwell Sauder. The network helps show where Maxwell Sauder may publish in the future.

Co-authorship network of co-authors of Maxwell Sauder

This figure shows the co-authorship network connecting the top 25 collaborators of Maxwell Sauder. A scholar is included among the top collaborators of Maxwell Sauder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxwell Sauder. Maxwell Sauder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lovegrove, Fiona, Maxwell Sauder, Asfandyar Mufti, et al.. (2025). Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management—A Canadian Perspective. Journal of Cutaneous Medicine and Surgery. 29(6). 661–674.
2.
Blauvelt, Andrew, Petr Arenberger, Maxwell Sauder, et al.. (2025). Highly selective, allosteric inhibition of TYK2 with oral ESK-001 in patients with moderate-to-severe plaque psoriasis: Results from STRIDE, a 12-week, randomized, double-blinded, placebo-controlled, dose-ranging phase 2 study. Journal of the American Academy of Dermatology. 94(1). 57–65. 2 indexed citations
3.
Cao, Jeffrey, Michael A. Yassa, Hannah Dahn, et al.. (2025). Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer: A Canadian Expert Perspective. International Journal of Radiation Oncology*Biology*Physics. 122(2). 267–274.
4.
Li, Wei, Jerome A. Feldman, Maxwell Sauder, et al.. (2025). 10MO: Preventing moderate to severe dermatologic adverse events in first-line EGFR-mutant advanced NSCLC treated with amivantamab plus lazertinib: Early success of the COCOON trial. Journal of Thoracic Oncology. 20(3). S14–S16. 5 indexed citations
6.
Sauder, Maxwell, Jerome A. Feldman, Wei Li, et al.. (2024). P3.12D.04 Enhanced vs Standard Dermatologic Management with Amivantamab-Lazertinib in Advanced NSCLC: Phase 2 COCOON Study. Journal of Thoracic Oncology. 19(10). S347–S347. 2 indexed citations
7.
Sauder, Maxwell, et al.. (2023). Kaposi sarcoma in a patient treated with upadacitinib for rheumatoid arthritis. JAAD Case Reports. 39. 145–149. 4 indexed citations
8.
Otto, T., Emily Baumrin, Adela R. Cardones, et al.. (2023). Detection of novel therapies using a multi‐national, multi‐institutional registry of cutaneous immune‐related adverse events and management. International Journal of Dermatology. 62(8). 1020–1025. 3 indexed citations
9.
Girnita, Ada, et al.. (2023). INDIVIDUAL ARTICLE: NECOM 3: A Practical Algorithm for the Management of Radiation Therapy-Related Acute Radiation Dermatitis. Journal of Drugs in Dermatology. 22(11). SF400354s3–SF400354s10. 1 indexed citations
10.
Said, Jordan T., et al.. (2022). Outcomes of Acitretin Treatment for Refractory Multikinase Inhibitor–Induced Hand-Foot Skin Reaction. JAMA Dermatology. 158(7). 824–824. 2 indexed citations
11.
Lacouture, Mario E., Jennifer Choi, Alice Y. Ho, et al.. (2021). US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm. Journal of Drugs in Dermatology. 20(9). 3ss–s19. 5 indexed citations
12.
Lynde, Charles, Jennifer Beecker, Joël Claveau, et al.. (2019). Clinical Insights About the Role of pH in Acne. PubMed. 18(12). 221–221. 4 indexed citations
13.
McDonald, Katherine, Maxwell Sauder, Nordau Kanigsberg, et al.. (2018). Usability, Satisfaction, and Usefulness of an Illustrated Eczema Action Plan. Journal of Cutaneous Medicine and Surgery. 22(6). 577–582. 6 indexed citations
14.
Sauder, Maxwell, John T. O’Malley, & Nicole R. LeBoeuf. (2017). CD30+ Lymphoproliferative Disorders of the Skin. Hematology/Oncology Clinics of North America. 31(2). 317–334. 22 indexed citations
15.
Sauder, Maxwell, et al.. (2015). Periorbital erythema following alcohol ingestion during treatment with topical tacrolimus. Canadian Medical Association Journal. 188(5). 368–368.
16.
Sauder, Maxwell & Melanie D. Pratt. (2015). Acrylate Systemic Contact Dermatitis. Dermatitis. 26(5). 235–238. 27 indexed citations
17.
Sauder, Maxwell, et al.. (2015). Acitretin-Induced Hepatitis: When to Monitor Cholestatic Enzymes. Journal of Cutaneous Medicine and Surgery. 19(2). 115–120. 8 indexed citations
18.
Sauder, Maxwell, et al.. (2014). Extragenital bullous lichen sclerosus. Journal of the American Academy of Dermatology. 71(5). 981–984. 12 indexed citations
19.
Sauder, Maxwell, et al.. (2014). Case 1: A premature infant with stridor. Paediatrics & Child Health. 19(8). 401–402. 1 indexed citations
20.
Sauder, Daniel N. & Maxwell Sauder. (2013). Molecular mechanisms in psoriasis: historical perspective and current pathogenesis. Expert Review of Dermatology. 8(1). 1–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026